At what point in the ADA and AACE sequencing algorithm for glycemic control in patients with T2D is the use of GLP-1 RA recommended? What are the treatment triggers for GLP-1 RA?

At what point in the ADA and AACE sequencing algorithm for glycemic control in patients with T2D is the use of GLP-1 RA recommended? What are the treatment triggers for GLP-1 RA?

At what point in the ADA and AACE sequencing algorithm for glycemic control in patients with T2D is the use of GLP-1 RA recommended? What are the treatment triggers for GLP-1 RA?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jane Reusch, MD

Jane Reusch, MD

Professor of Medicine and Biochemistry University of Colorado Denver and Denver VAMC Denver, Colorado